Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.50 (0.16%)
Bid:
304.50
Ask:
305.00
Spread: 0.50 (0.164%)
Market Cap: £180.06m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Relationship Agreement and Board Appointment

20 Jan 2026 07:01

RNS Number : 5844P
Treatt PLC
20 January 2026
 

TREATT PLC

("Treatt" or "the Group")

Relationship Agreement with Döhler

and

Board appointment

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces that it has entered into a customary relationship agreement with major shareholder Döhler Finance Management B.V. and the appointment of Helga Moelschl as a Non-Executive Director of the Company.

Relationship Agreement

In light of its significant shareholding of 16,616,021 shares (representing approximately 28% of the issued share capital of the Company), Treatt entered into a customary relationship agreement with Döhler Finance Management B.V. ("Döhler") on 19 January 2026, which regulates the relationship between the Company and Döhler (the "Relationship Agreement").

In the Relationship Agreement, Döhler has undertaken, among other matters, to ensure that all transactions and arrangements between it and the Company will be conducted at arm's length and on normal commercial terms. Döhler has also agreed that it will not take any action or propose any shareholder resolution that would prevent the Company from complying with its obligations under the UK Listing Rules and other applicable regulatory requirements. The Relationship Agreement contains customary provisions governing the protection of confidential information by the Company with Döhler.

The Relationship Agreement also gives Döhler the right to nominate one candidate for appointment to the Board as a director of the Company for so long as the agreement is in effect, subject to prior consultation with the Board, the completion of customary due diligence and provided the relevant candidate fits the skills and experience profile required by the Board at the relevant time. 

The Relationship Agreement will terminate if Döhler's shareholding falls below 25 per cent. of the issued ordinary share capital of the Company.

Director appointment

Further to the entering into of the Relationship Agreement, Treatt announces that Helga Moelschl will join the Board as a Non-Executive Director on 1 February 2026. Helga's nomination was considered by the Company's Nomination Committee, which recognised Helga's significant industry experience.

Helga brings over 20 years' experience in the food ingredients and flavours industry and has held senior roles at leading companies in the sector, including IFF and Givaudan. During her career Helga has established a strong track record of business performance leadership, commercial excellence and sustainable value creation, underpinned by innovative consumer-centric strategies.

Helga was nominated by Döhler under the terms of the Relationship Agreement and she will consequently be classified as non-independent for the purpose of the UK Corporate Governance Code.

Treatt Chair, Vijay Thakrar said:

"The Board is committed to acting in the interests of all its shareholders. I am pleased to announce the Relationship Agreement with Döhler, which is both a significant shareholder and a highly respected company in the ingredients, life science and nutrition industry. After careful consideration, the Board concluded that it would be in the Company's best interest to enter into a suitable agreement with Döhler to regulate our relationship for the benefit of all shareholders and stakeholders of the Company. 

"I am also pleased to welcome Helga to the Board. Helga brings significant commercial experience of our industry from her time with IFF and Givaudan. I, and my Board colleagues, look forward to working with her."

There are no further matters to be disclosed pursuant to LR6.4.8R of the FCA's Listing Rules.

 

Treatt PLC (via MHP)

Vijay Thakrar Chair

Joint Brokers

Investec Bank Plc +44 (0) 20 7597 5970

David Anderson

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Financial PR

MHP + 44 (0) 7885 447 944

Tim Rowntree Treatt@mhpgroup.com

Eleni Menikou

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field. The Group employs approximately 350 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

For further information about the Group, visit www.treatt.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFFRLIIIFIR
Date   Source Headline
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend
28th Nov 20237:00 amRNSFull Year Results
20th Oct 20237:00 amRNSCEO Succession
10th Oct 20237:00 amRNSTrading Update
18th Sep 20234:11 pmRNSHolding(s) in Company
15th Aug 20234:14 pmRNSNotification of Transactions of Directors
28th Jul 202310:43 amRNSTotal Voting Rights
13th Jul 202312:15 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202311:09 amRNSNotification of Transaction of Director
21st Jun 20234:05 pmRNSNotification of Transactions of Director
12th Jun 20234:13 pmRNSDirector Declaration
7th Jun 20232:28 pmRNSBlock Listing Application
1st Jun 20237:00 amRNSBlock listing Six Monthly Return
19th May 20235:10 pmRNSHolding(s) in Company
19th May 20234:28 pmRNSHolding(s) in Company
9th May 20237:00 amRNSHalf Year Results
12th Apr 20237:00 amRNSHalf Year Trading Update and Notice of Results
20th Mar 20233:28 pmRNSNotification of Transactions of Directors
7th Mar 20233:25 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:06 pmRNSHolding(s) in Company
21st Feb 202312:51 pmRNSNotification of Transactions of Director
21st Feb 202312:49 pmRNSNotification of Transactions of Director
20th Feb 202311:01 amRNSNotification of Transaction of a Director
30th Jan 20231:49 pmRNSHolding(s) in Company
27th Jan 20233:10 pmRNSResult of AGM
27th Jan 20237:00 amRNSAGM Trading Update
10th Jan 20235:05 pmRNSVoting Rights and Capital
28th Dec 20227:00 amRNSNotification of Transaction of Director
28th Dec 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Dec 202212:20 pmRNSBoard Appointment and Board Committee Changes
16th Dec 20221:25 pmRNSNotification of Transactions of Directors
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Nov 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20227:10 amRNSFull Year Results
10th Nov 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.